Processa Pharmaceuticals, Inc. Treasury Stock, Common, Shares
Processa Pharmaceuticals, Inc. (PCSA) had Treasury Stock, Common, Shares of 200 shares as of 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:TreasuryStockCommonShares · last filed 2026-03-18
- 2025-12-31: Treasury Stock, Common, Shares 200.00 shares.
- 2025-09-30: Treasury Stock, Common, Shares 5.00K shares.
- 2025-06-30: Treasury Stock, Common, Shares 5.00K shares.
- 2025-03-31: Treasury Stock, Common, Shares 5.00K shares.
| Period end | Treasury Stock, Common, Shares | Treasury Stock, Common, Shares as first filed |
|---|---|---|
| 2025-12-31 | 200.00 shares 10-K · filed 2026-03-18 | |
| 2025-09-30 | 5.00K shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 5.00K shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 5.00K shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 200.00 shares 10-K · filed 2026-03-18 | 5.00K shares 10-K · filed 2025-03-20 |
| 2024-09-30 | 5.00K shares 10-Q · filed 2024-10-30 | |
| 2024-06-30 | 5.00K shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 5.00K shares 10-Q · filed 2024-05-10 | |
| 2023-12-31 | 5.00K shares 10-K · filed 2025-03-20 | |
| 2023-09-30 | 100.00K shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 100.00K shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 100.00K shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 100.00K shares 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |